Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Yoshikuni Mizuno

Showing results (1-10 of 206) with videos related to

Pageof 21
Sort By:
Nihon Naika Gakkai Zasshi. the Journal of the Japanese Society of Internal Medicine|March 31, 2005
[Studies on pathogenesis of Parkinson's disease]Yoshikuni Mizuno
Nihon Naika Gakkai Zasshi. the Journal of the Japanese Society of Internal Medicine|October 11, 2002
[Progress in diagnosis and therapy for Parkinson's disease]Yoshikuni Mizuno
Rinsho Shinkeigaku = Clinical Neurology|January 18, 2005
[Progress in the basic and clinical aspects of Parkinson's disease]Yoshikuni Mizuno
Nihon Rinsho. Japanese Journal of Clinical Medicine|October 7, 2004
[Progress in Parkinson's disease]Yoshikuni Mizuno
Rinsho Shinkeigaku = Clinical Neurology|January 24, 2008
[Discovery of the parkin gene; the gene for young onset autosomal recessive parkinsonism (AR)]Yoshikuni Mizuno
Nihon Naika Gakkai Zasshi. the Journal of the Japanese Society of Internal Medicine|October 15, 2005
[In pursuit of the causes for Parkinson disease]Yoshikuni Mizuno
Neuroscience Research|May 26, 2020
More than 20 years of the discovery of Park2Yoshikuni Mizuno
Lancet (London, England)|August 25, 2004
Pathogenetic mechanisms of parkin in Parkinson's diseaseNobutaka Hattori, Yoshikuni Mizuno
Neurology|November 27, 2002
Absence of linkage to 8q24 in a European family with familial adult myoclonic epilepsy (FAME)Yasuyuki Okuma, Yoshikuni Mizuno
Movement Disorders : Official Journal of the Movement Disorder Society|March 14, 2013
Adenosine A2A receptor antagonist istradefylline reduces daily OFF time in Parkinson's diseaseYoshikuni Mizuno, Tomoyoshi Kondo,
Pageof 21

Showing results (1-10 of 206) with videos related to

Sort By:
Pageof 21
Nihon Naika Gakkai Zasshi. the Journal of the Japanese Society of Internal Medicine|March 31, 2005
[Studies on pathogenesis of Parkinson's disease]Yoshikuni Mizuno
Nihon Naika Gakkai Zasshi. the Journal of the Japanese Society of Internal Medicine|October 11, 2002
[Progress in diagnosis and therapy for Parkinson's disease]Yoshikuni Mizuno
Rinsho Shinkeigaku = Clinical Neurology|January 18, 2005
[Progress in the basic and clinical aspects of Parkinson's disease]Yoshikuni Mizuno
Nihon Rinsho. Japanese Journal of Clinical Medicine|October 7, 2004
[Progress in Parkinson's disease]Yoshikuni Mizuno
Rinsho Shinkeigaku = Clinical Neurology|January 24, 2008
[Discovery of the parkin gene; the gene for young onset autosomal recessive parkinsonism (AR)]Yoshikuni Mizuno
Nihon Naika Gakkai Zasshi. the Journal of the Japanese Society of Internal Medicine|October 15, 2005
[In pursuit of the causes for Parkinson disease]Yoshikuni Mizuno
Neuroscience Research|May 26, 2020
More than 20 years of the discovery of Park2Yoshikuni Mizuno
Lancet (London, England)|August 25, 2004
Pathogenetic mechanisms of parkin in Parkinson's diseaseNobutaka Hattori, Yoshikuni Mizuno
Neurology|November 27, 2002
Absence of linkage to 8q24 in a European family with familial adult myoclonic epilepsy (FAME)Yasuyuki Okuma, Yoshikuni Mizuno
Movement Disorders : Official Journal of the Movement Disorder Society|March 14, 2013
Adenosine A2A receptor antagonist istradefylline reduces daily OFF time in Parkinson's diseaseYoshikuni Mizuno, Tomoyoshi Kondo,
Pageof 21